Evidence check: the medium and long-term sequelae of COVID-19, New South Wales Government COVID-19 Critical Intelligence Unit
Rapid review question: What are the medium- and long-term health sequelae of COVID-19 infection among survivors? In brief: General health sequelae • Symptoms commonly reported among recovered COVID-19 patients two to eight weeks after the onset of symptoms (or a positive COVID-19 test) include: fatigue, shortness of breath, muscle or joint pain, chest pain, cough, and insomnia and/or sleep disorders.(1-6) • A study of 202 confirmed COVID -19 patients with mild symptoms, found altered sense of smell or taste occurred in 18.6% of patients, feelings of being tired in 13.1%, problems breathing in 10.4% and muscle or ...
Source: Current Awareness Service for Health (CASH) - September 17, 2020 Category: Consumer Health News Source Type: news

How Is a Pulmonary Function Test Performed?
Title: How Is a Pulmonary Function Test Performed?Category: Procedures and TestsCreated: 7/15/2020 12:00:00 AMLast Editorial Review: 7/15/2020 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - July 15, 2020 Category: Respiratory Medicine Source Type: news

Roche launches new blood gas digital solution designed to improve patient care
Basel, 15 May 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE mark availability of Roche v-TAC, a new digital diagnostic solution that allows clinicians to obtain results for arterial blood gas values from patients with respiratory or metabolic abnormalities via a simpler, less invasive venous puncture through the use of a digital algorithm. Blood gas analysis is typically used in hospital point of care (POC) settings, where quick and accurate results are needed. This includes emergency rooms, intensive care units and operating rooms. The analysis provides clinicians with information about a patient &rsquo...
Source: Roche Investor Update - May 15, 2020 Category: Pharmaceuticals Source Type: news

Roche launches new blood gas digital solution designed to improve patient care
Basel, 15 May 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE mark availability of Roche v-TAC, a new digital diagnostic solution that allows clinicians to obtain results for arterial blood gas values from patients with respiratory or metabolic abnormalities via a simpler, less invasive venous puncture through the use of a digital algorithm. Blood gas analysis is typically used in hospital point of care (POC) settings, where quick and accurate results are needed. This includes emergency rooms, intensive care units and operating rooms. The analysis provides clinicians with information about a patient &rsquo...
Source: Roche Media News - May 15, 2020 Category: Pharmaceuticals Source Type: news

Are Your Lungs at Risk?
As our national lockdown drags on, the media repeats the same message… Isolation is the only solution. You must stay home, avoid other people, stay away from your office, give up on recreation and socializing… But maybe there’s a different way to handle this. Throughout my career — and especially here at the Sears Institute for Anti-Aging Medicine — I’ve sought to make my patients, employees, and readers healthier, more vital, and more resistant to disease. Few people are talking about why this virus is mostly a threat to elders or people who already have a disease diagnosis. Truth...
Source: Al Sears, MD Natural Remedies - May 8, 2020 Category: Complementary Medicine Authors: Dr.A.Sears Tags: Fitness Health Source Type: news

Gala Therapeutics launches RheOx chronic bronchitis trial
Gala Therapeutics said today that it launched an early feasibility study of its RheOx system for treating chronic bronchitis, and that the first two patients in the trial have already been enrolled. Initial patient enrollment took place at the University of Pittsburgh Medical Center, with RheOx bronchial rheoplasty procedures performed by Dr. Frank Sciurba and Roy Semaan, the Menlo Park, Calif.-based company said. “We are pleased to partner with Gala in treating the first US patients and thus continuing the contribution of UPMC as a leader in the development of novel devices for our patients with COPD. RheOx off...
Source: Mass Device - November 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Respiratory galatherapeutics Source Type: news

How a New Emphysema Device Won FDA Approval in Six Months
FDA has approved a new device intended to treat breathing difficulty associated with severe emphysema. The approval comes just two weeks after an FDA advisory panel shot down a competing technology targeting the same patient population. The agency approved Pulmonx Inc.'s Zephyr endobronchial valve through the breakthrough device designation, a pathway reserved for devices that provide for more effective treatment or diagnosis of a life-threatening or irreversibly debilitating disease or condition. Devices also must meet one of the following criteria: the device must represent a breakthrough technology; there must be no app...
Source: MDDI - July 2, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news

Reference Equations for Spirometric Indices Reference Equations for Spirometric Indices
Spirometric measurements from a sample of adult Nigerians provides updated reference data for interpreting pulmonary function test results.BMC Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 31, 2017 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

Pulmonary function test findings in patients with acute inhalation injury caused by smoke bombs - Cao L, Zhang XG, Wang JG, Wang HB, Chen YB, Zhao DH, Shi WF, Xie LX.
This study aimed to determine the effects of smoke bomb-induced acute inhalation injury on pulmonary function at different stages of lung injury. METHODS: We performed pulmonary function tests (PFTs) in 15 patients with acute inhalation... (Source: SafetyLit)
Source: SafetyLit - January 14, 2017 Category: Global & Universal Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Osmosis Question of the Week July 29, 2016 Osmosis Question of the Week July 29, 2016
Do you know what pulmonary function test findings to expect in a 67-year-old man who is out of breath? Osmosis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 29, 2016 Category: Consumer Health News Tags: Med Students Interactive Quiz Source Type: news

Lung disease in smokers who don’t have COPD
This study affirms that these people can experience serious health consequences, even without COPD. This finding also brings into question how we should classify chronic respiratory disease. So far, we haven’t determined a way of classifying those who have symptoms but don’t quite meet the usual criteria for COPD, and we also don’t have much data or guidance on how best to treat them. In the meantime, quitting smoking remains the best way to lower your chances of getting COPD — and the best way to lessen any respiratory symptoms you’re having. Most smokers who stop will feel better, with less ...
Source: New Harvard Health Information - June 9, 2016 Category: Consumer Health News Authors: Wynne Armand, MD Tags: Health Lung disease Smoking cessation COPD Source Type: news

Solving Addison’s puzzle: Uncovering a congenital heart defect
Addison is a smart, sweet and caring child who brings a smile to everyone she meets. She is known for her hugs and frequently doles them out to anyone and everyone. She loves elephants—and her heart is elephant-sized! However, until last fall, Addison’s heart was causing mysterious and persistent medical issues that prevented her from doing all the things she loves. Unbeknownst to my husband and me, Addison was born with a congenital heart defect. As a baby, Addison thrived but always seemed to have something going on. She had issues with reflux and did not enjoy tummy time or sleeping on her back. Waking sever...
Source: Thrive, Children's Hospital Boston - May 21, 2015 Category: Pediatrics Authors: Kristine Hogan Tags: Heart conditions Our patients’ stories cardiac surgery congenital heart defect congenital heart disease Heart Center Source Type: news

Hot Topics: COPD Tests and Treatment Planning
(MedPage Today) -- How do pulmonary function test results influence treatment in COPD? (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - November 19, 2014 Category: Primary Care Source Type: news

Finally, Some Good News!
Sarepta’s 120 week stability data on both the six minute walk test, as well as, pulmonary function is good news. (Source: Parent Project Muscular Dystrophy)
Source: Parent Project Muscular Dystrophy - February 10, 2014 Category: Neurology Source Type: news